Technosphere Insulin System: Phase IIb data

In a 12-week, double-blind, placebo-controlled, U.S. Phase IIb trial in 123 patients, significantly more patients

Read the full 152 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE